Dow Jones

38 589,16

-0,15%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
CytRx Corp (QB) (CYTR)
CytRx Corp (QB) (CYTR) Actualités

CYTR

CytRx (QB) (CYTR)

CytRx Corp (QB)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:CYTR

Date	Heure	Source	Titre	Symbole	Société
26/06/2023	12h21	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CYTR	CytRx Corp (QB)
15/05/2023	12h29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CYTR	CytRx Corp (QB)
20/03/2023	11h08	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CYTR	CytRx Corp (QB)
14/02/2023	19h04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CYTR	CytRx Corp (QB)
29/07/2022	01h03	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CYTR	CytRx Corp (QB)
28/07/2022	22h06	Edgar (US Regulatory)	Amended Small Company Offering and Sale of Securities Without Registration (d/a)	USOTC:CYTR	CytRx Corp (QB)
16/06/2022	22h16	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CYTR	CytRx Corp (QB)
16/06/2022	12h08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CYTR	CytRx Corp (QB)
03/06/2022	22h11	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:CYTR	CytRx Corp (QB)
19/05/2022	23h04	Edgar (US Regulatory)	Securities Registration (section 12(g)) (8-a12g)	USOTC:CYTR	CytRx Corp (QB)
28/03/2022	12h05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:CYTR	CytRx Corp (QB)
25/03/2022	21h20	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:CYTR	CytRx Corp (QB)
15/02/2022	12h30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:CYTR	CytRx Corp (QB)
12/01/2022	16h59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:CYTR	CytRx Corp (QB)
04/08/2021	22h31	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:CYTR	CytRx Corp (QB)
29/07/2021	12h08	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:CYTR	CytRx Corp (QB)
13/07/2021	12h01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:CYTR	CytRx Corp (QB)
18/06/2021	18h07	Dow Jones News	Orphazyme, CytRx Shares Slide as FDA Rejects Arimoclomol	USOTC:CYTR	CytRx Corp (QB)
22/04/2021	12h16	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:CYTR	CytRx Corp (QB)
17/11/2020	12h11	Edgar (US Regulatory)	Amended Securities Registration (section 12(g)) (8-a12g/a)	USOTC:CYTR	CytRx Corp (QB)
23/10/2020	13h43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:CYTR	CytRx Corp (QB)
25/08/2020	16h12	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	USOTC:CYTR	CytRx Corp (QB)
13/08/2020	15h30	Edgar (US Regulatory)	Proxy Statement - Non-management (definitive) (defn14a)	USOTC:CYTR	CytRx Corp (QB)
10/08/2020	14h56	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prrn14a)	USOTC:CYTR	CytRx Corp (QB)
10/08/2020	12h05	Edgar (US Regulatory)	Proxy Statment - Contested Solicitations (definitive) (defc14a)	USOTC:CYTR	CytRx Corp (QB)
20/07/2020	15h27	Edgar (US Regulatory)	Proxy Statement - Contested Solicitations (preliminary) (prec14a)	USOTC:CYTR	CytRx Corp (QB)
27/05/2020	12h06	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:CYTR	CytRx Corp (QB)